ABGENOMICS
AbGenomics develops targeted antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases.
ABGENOMICS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical Sales
Founded:
2000-01-01
Address:
Los Altos, California, United States
Country:
United States
Website Url:
http://www.abgenomics.com
Total Employee:
11+
Status:
Active
Contact:
+1 650 988 9912
Official Site Inspections
http://www.abgenomics.com
- Host name: 199.59.243.228
- IP address: 199.59.243.228
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Abgenomics"
AltruBio - Crunchbase Company Profile & Funding
With its R&D foundation in Taipei Taiwan since June 2000, AbGenomics has been focusing on the discovery and development of novel therapeutics for …See details»
Abgenomics - Crunchbase Company Profile & Funding
Organization. Abgenomics . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. AbGenomics Corporation is a biotechnology company. ...See details»
AbGenomics International Inc. Information - RocketReach
AbGenomics International Inc. (AbG), incorporated in Delaware in 2006 with its principal office in San Francisco Bay Area, California, is a clinical stage biopharmaceutical company. …See details»
abgenomics - Overview, News & Similar companies | ZoomInfo.com
Who is abgenomics. AbGenomics International Inc., incorporated in Delaware with principal office in SFO Bay Area California, is a biopharmaceutical company integrated globally and virtually …See details»
Abgenomics - Genomics.org
Founded by a group of leading biomedical scientists in June 2000, AbGenomics Corporation is a biopharmaceutical company focusing on the discovery and development of novel therapeutic …See details»
AltruBio Company Profile - Office Locations, Competitors ... - Craft
AltruBio (formerly AbGenomics) is a biopharmaceutical company focused on developing antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases. It builds a …See details»
TaiwanBiotechCompanies asiabiotech - AltruBio
And clinicians , AbGenomics shows great potential in the pursuit of novel pharmaceuticals. AbGenomics Corporation 2F, No.32, Lane 358 Juikuang Road, Neihu, Taipei, Taiwan Tel: …See details»
AbGenomics International, Inc. - Drug pipelines, Patents, Clinical ...
Mar 8, 2025 Drugs associated with AbGenomics International, Inc. Leiolizumab. Target. PSGL-1. Mechanism. PSGL-1 agonists [+2] Active Org. Altrubio, Inc. [+1] Originator Org. ... The …See details»
AbGenomics International - VentureRadar
Find out more about AbGenomics International, Antibodies, Biologics and Antibody Therapeutics. All; Ranked; Organisation Names; Apps and Links. Homepage (myVR) Funding Deals Hub; …See details»
AbGenomics International, Inc. (AbGenomics International, Inc.)
了解AbGenomics International, Inc. (AbGenomics International, Inc.)公司的药物管线，治疗领域，技术平台，以及它的12篇新闻，疾病领域:肿瘤，免疫系统疾病，内分泌与代谢疾病，感 …See details»
AbGenomics International Inc - Company Profile and News
AbGenomics International Inc. develops therapeutics for cancer. The Company develops and markets targeted antibody therapeutics for the treatment of cancer and immune related …See details»
New name, new board, new focus: AltruBio relaunches with $63M …
Apr 15, 2021 Formerly known as AbGenomics Holding Inc., AltruBio's two antibody-targeted therapies are under development in six disease areas. Neihulizumab is the leading candidate, …See details»
AbGenomics Corporation - LinkedIn
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis - GRAPPA Non-profit Organizations Seattle, WashingtonSee details»
AbGenomics International, Inc. - Drug pipelines, Patents, Clinical ...
Explore AbGenomics International, Inc. with its drug pipeline, therapeutic area, technology platform, 14 news, Disease Domain:Neoplasms, Immune System Diseases ...See details»
abgenomics Company Profile | Management and Employees List
Abgenomics Profile and History AbGenomics International Inc., incorporated in Delaware with principal office in SFO Bay Area California, is a biopharmaceutical company integrated …See details»
AbGenomics Holding Inc. Announces Company Name Change to …
On June 15, 2020 AbGenomics Holding Inc., a clinical stage biotech company, announced today that the company will be operating under a new name, AltruBio Inc., effective immediately …See details»
AbGenomics | IT History Society
AbGenomics is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.AbGenomics International Inc., incorporated in …See details»
AltruBio secures up to $225M after pivot to immune drug research
Jun 27, 2024 Biotechnology startup AltruBio recently secured a Series B funding round which could provide up to $225 million, continuing to benefit from a strategic shift made four years …See details»
Abgenomics International Inc. (Abgenomics International Inc.) - 药 …
了解Abgenomics International Inc. (Abgenomics International Inc.)公司的药物管线，治疗领域，技术平台，以及它的3篇新闻和1篇文献。 ... a new biosimilar policy called the 'Guidelines on …See details»
Abgenomics International Inc. - Drug pipelines, Patents, Clinical ...
Explore Abgenomics International Inc. with its drug pipeline, therapeutic area, technology platform, 2 news, and 1 literature. ... a new biosimilar policy called the 'Guidelines on Similar …See details»